Class solution for inversely planned permanent prostate implants to mimic an experienced dosimetrist

Medical Physics

Volumn 33, Issue 8, 2006, Pages 2773-2782

  Lessard, Etienne ^a   Kwa, Stefan L S ^b   Pickett, Barby ^a   Roach III, Mach ^a   Pouliot, Jean ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DOSIMETRY; NEEDLES; PATIENT TREATMENT; UROLOGY;

INTRA-OPERATIVE; INVERSE PLANNING; PLANNING PROCESS; PROSTATE IMPLANTS; PROSTATE VOLUME; REAL-TIME PLANNING; TREATMENT PLANNING; TREATMENT PLANNING SYSTEMS;

EQUIVALENCE CLASSES;

ARTICLE; DOSIMETRY; IMPLANT; PERMANENT PROSTATE IMPLANT; PRIORITY JOURNAL; PROSTATE; TREATMENT PLANNING; URETHRA;

EID: 33746637538     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.2210565     Document Type: Article

References (32)

1. H. Radge et al.., "Modern prostate brachytherapy: Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up," Cancer 89, 135-141 (2000).
2. D. G. Brachman et al., "Failure-free survival following brachytherapy alone or external beam irradiation alone for T1-2 prostate tumors in 2222 patients: Results from a single practice," Int. J. Radiat. Oncol., Biol., Phys. 48, 111-117 (2000).
3. P. D. Grimm et al., "Ten year biochemical (prostate-specific antigen) control of prostate cancer with 125I brachytherapy," Int. J. Radiat. Oncol., Biol., Phys. 51, 31-40 (2001).
4. Y. Yu et al., "Permanent prostate seed implant brachytherapy: Report of the American Association of Physicist in Medicine Task Group No. 64," Med. Phys. 26, 2054-2076 (1999).
5. J. E. Dawson et al., "Dose effect of seeds placement deviation from preplanned positions in ultrasound guided prostate implants," Radiother. Oncol. 32, 268-270 (1994).
6. P. L. Roberson et al., "Source placement error for permanent implant of the prostate," Med. Phys. 24, 251-257 (1997).
7. R. Taschereau, J. Roy, and J. Pouliot, "Seed misplacement and stabilizing needles in transperineal permanent prostate implants," Radiother. Oncol. 55, 59-63 (2000).
8. E. M. Messing et al., "Intraoperative optimized inverse planning for prostate brachytherapy: Early experience," Int. J. Radiat. Oncol., Biol., Phys. 44, 801-808 (1999).
9. D. C. Beyer, R. H. Shapiro, and F. Puente, "Real time optimized intraoperative dosimetry for prostate brachytherapy: A pilot study," Int. J. Radiat. Oncol., Biol., Phys. 48, 1583-1589 (2000).
10. D. A. Wilkinson et al., "Dosimetric comparison of pre-planning and OR-planned prostate seed brachytherapy," Int. J. Radiat. Oncol., Biol., Phys. 48, 1241-1244 (2000).
11. M. J. Zelefsky et al., "Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy," Int. J. Radiat. Oncol., Biol., Phys. 55, 956-963 (2003).
12. S. Nag et al., "Intraoperative planning and evaluation of the permanent prostate brachytherapy: Report of the American Brachytherapy Society," Int. J. Radiat. Oncol., Biol., Phys. 51, 1422-1430 (2001).
13. P. Xia et al., "A study of planning dose constraints for treatment of nasopharyngeal carcinoma using a commercial inverse treatment planning system," Int. J. Radiat. Oncol., Biol., Phys. 59, 886-896 (2004).
14. V. S. Khoo et al., "Class solutions for conformal external beam prostate radiotherapy," Int. J. Radiat. Oncol., Biol., Phys. 55, 1109-1120 (2003).
15. J. H. Mott, J. E. Livsey, and J. P. Logue, "Development of a simultaneous boost IMRT class solution for a hypofractionated prostate cancer protocol," Br. J. Radiol. 77, 377-386 (2004).
16. M. Rivard, D. A. R. Evans, and I. Kay, "A technical evaluation of the Nucletron FIRST system: Conformance of a remote afterloading brachytherapy seed implantation system to manufacturer specifications and AAPM Task Group report recommendations," J. Appl. Clin. Med. Phys. 6, 22-50 (2005).
17. B. Pickett and J. Pouliot, "Prostate Brachytherapy," The Modern Technology of Radiation Therapy, Vol. 2, edited by J. Vandyk (Medical Physics Publishing, Philadelphia, 2005).
18. E. Lessard and J. Pouliot, "Inverse planning anatomy based dose optimization for HDR-brachytherapy of the prostate using fast simulated annealing algorithm and dedicated objective function," Med. Phys. 28, 773-779 (2001).
19. E. Lessard, "Development and clinical introduction of an inverse planning dose optimization by simulated annealing (IPSA) for high dose rate brachytherapy," Thesis abstract, Med. Phys. 31, 2935 (2004).
20. J. Pouliot, E. Lessard, and I.-C. Hsu, "Advanced 3D Planning," in Brachytherapy Physics, 2nd ed. (Medical Physics Publishing, Madison, 2005), chap 21.
21. E. Lessard, I-C. Hsu, and J. Pouliot, "Inverse planning for interstitial gynecological template brachytherapy: Truly anatomy based planning," Int. J. Radiat. Oncol., Biol., Phys. 54, 1243-1250 (2002).
22. B. Lachance et al., "Early clinical experience with anatomy-based inverse planning dose optimization for high-dose-rate boost of the prostate," Int. J. Radiat. Oncol., Biol., Phys. 54, 86-100 (2002).
23. I-C. Hsu, E. Lessard, V. Weinberg, and J. Pouliot, "Comparison of inverse planning simulated annealing and geometrical optimization for prostate high dose rate brachytherapy," Brachytherapy 3, 147-152 (2004).
24. C. Ménard et al., "MRI-guided HDR prostate brachytherapy in standard 1.5 T scanner," Int. J. Radiat. Oncol., Biol., Phys. 59, 1414-1423 (2004).
25. K. D. DeWitt, I-C. Hsu, J. Speight, V. K. Weinberg, E. Lessard, and J. Pouliot, "3D Inverse treatment planning for the tamdem and ovoid applicator in cervival cancer," Int. J. Radiat. Oncol., Biol., Phys. 63, 1270-1274 (2005).
26. R. S. Sloboda, "Optimization of brachytherapy dose distribution by simulated annealing," Med. Phys. 19, 955-964 (1992).
27. 125I prostate implants using fast simulated annealing," Int. J. Radiat. Oncol., Biol., Phys. 36, 711-720 (1996).
28. A. T. Redpath, "Automatic determination of needle and source positions for brachytherapy of the prostate using 125Iodine rapid strand," Radiother. Oncol. 65, 215-227 (2002).
29. J. Speight et al., "Prostate volume change after radioactive seed implantation: Possible benefit of improved dose volume histogram with perioperative steroid," Int. J. Radiat. Oncol., Biol., Phys. 48, 1461-1467 (2000).
30. L. Eapen et al., "Correlating the degree of needle trauma during prostate brachytherapy and the development of acute urinary toxicity," Int. J. Radiat. Oncol., Biol., Phys. 59, 1392-1394 (2004).
31. J. N. Roy et al., "Determining source strength and source distribution for a transperineal prostate implant," Endocurietherapy/ Hyperthermia Oncol. 12, 35-42 (1996).
32. L. Beaulieu et al., "The robustness of dose distributions to displacement and migration of 125I permanent seed implants over a wide range of seed number, activity, and designs," Int. J. Radiat. Oncol., Biol., Phys. 58, 1298-1308 (2004).